Content Loading...
Content Loading...
Last Item Added: 0 Items
Content Loading...
» Close

Millipore Technical Publications


SDS1706ENEU.pdf
DS- SDS1706ENEU

MicroSafe Biosafety Solutions Laboratory, Europe - Adventitious Virus Testing

Lit No:SDS1706ENEU
Year:2006


A major concern when using mammalian cell lines for production of a biotechnology product is the risk of viral contamination. Such contamination could have serious clinical consequences; in particular, the administration of the contaminated drug could be detrimental to the patient. Drug contamination can arise through the introduction of adventitious (accidentally introduced) viruses during the manufacturing process. The likely sources of contamination include the use of contaminated cell culture media, a breakdown in GMP allowing operator or other external contamination, or the use of contaminated reagents used in the process, such as a monoclonal antibody affinity chromatography column.

Click the PDF above for the full document.